Amgen And QB3@953 Announce Winners Of The Amgen Golden Ticket

Two Diagnostic Companies Will Receive Lab Space and Other Benefits at San Francisco Life Sciences Incubator SAN FRANCISCO, July 11, 2017 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and QB3@953 today announced that Darmiyan and Enable Biosciences have won the Amgen Golden Ticket at QB3@953. Each company receives one year of lab space at the QB3@953 life sciences incubator, additional facility benefits and connections to Amgen's scientific and business leaders to help advance their scientific programs. The Amgen Golden Ticket program was launched by Amgen in 2015 to assist early-stage life sciences companies in their efforts to advance biology and technologies for the benefit of patients sufferi...
Source: Amgen News Release - Category: Pharmaceuticals Tags: Uncategorized Source Type: news